Basket

0099656 - MBÚ 2008 RIV GB eng C - Conference Paper (international conference)
Tomala, Jakub - Kovář, Marek - Mrkvan, Tomáš - Etrych, Tomáš - Strohalm, Jiří - Ulbrich, Karel - Říhová, Blanka
Treatment of expanding tumors by targeted HPMA copolymer-bound doxorubicin conjugates is followed by specific anti-tumour immunity.
[Léčba expandujících nádorů směrovanými polymerními léčivy s doxorubicinem je následováno specifickou protinádorovou imunitou.]
Meeting of the International Society for Oncodevelopmental Biology and Medicine, ISOBM 2007 /35./. London: Karger, 2007, s. 88-88. ISSN 1010-4283.
[Meeting of the International Society for Oncodevelopmental Biology and Medicine, ISOBM 2007 /35./. Prague (CZ), 15.09.2007-19.09.2007]
R&D Projects: GA AV ČR KAN200200651
Institutional research plan: CEZ:AV0Z50200510; CEZ:AV0Z40500505
Keywords : doxorubicin
Subject RIV: EC - Immunology
Permanent Link: http://hdl.handle.net/11104/0158207